These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2976598)

  • 21. Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease.
    Wald DS; Morton G; Walker K; Iosson N; Curzen NP
    Ann Pharmacother; 2007 Oct; 41(10):1644-7. PubMed ID: 17785612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular drugs and exercise interactions.
    Kendrick ZV; Cristal N; Lowenthal DT
    Cardiol Clin; 1987 May; 5(2):227-44. PubMed ID: 3555797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of methods for research on the clinical pharmacology of drugs used in cardiovascular diseases].
    Lozinskiĭ LG; Venediktova MG; Zakharova GIu; Sandomirskiĭ BL
    Farmakol Toksikol; 1986; 49(5):60-2. PubMed ID: 3533621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment and cost of cardiovascular disease in Australia.
    Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
    Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term effects of prescription drugs in 174 patients treated for myocardial infarction, followed up from 4 to 5 years (the DEVENIR study)].
    Graille V; Ferrières J; Marques-Vidal P; Ruidavets JB; Rodier P; Cambou JP
    Arch Mal Coeur Vaiss; 1996 Jan; 89(1):35-9. PubMed ID: 8678736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical chronopharmacology of the cardiovascular system: hypertension and coronary heart disease.
    Lemmer B
    Clin Ter; 2006; 157(1):41-52. PubMed ID: 16669551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thirty-five years of progress in cardiovascular research.
    Braunwald E
    Circulation; 1984 Nov; 70(5 Pt 2):III8-25. PubMed ID: 6386225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Scientific bases for the effective use of drugs in medical care based on an analysis of drug utilization. Goal and content of utilization analysis. Use of analysis results in the collaboration of pharmaceutical and medical care areas].
    Görlt H; Lohmann D
    Z Arztl Fortbild (Jena); 1984; 78(16):661-6. PubMed ID: 6495784
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heart failure due to diastolic dysfunction: the treatment principles].
    Pinamonti B; di Lenarda A; Sinagra G
    Ital Heart J Suppl; 2000 Apr; 1(4):469-80. PubMed ID: 10832133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular drugs and the older adult.
    Potempa K; Roberts KV
    Nurs Clin North Am; 1982 Jun; 17(2):263-74. PubMed ID: 6919936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in antihypertensive drugs in the elderly: the decline of thiazides.
    Onder G; Gambassi G; Landi F; Pedone C; Cesari M; Carbonin PU; Bernabei R;
    J Hum Hypertens; 2001 May; 15(5):291-7. PubMed ID: 11378830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of utilization of cardiovascular drugs in the Czech Republic and in Wales].
    Górecká K; Vlcek J; Walker R
    Vnitr Lek; 2003 Aug; 49(8):592-7. PubMed ID: 14518081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based cardiovascular therapies and achievement of therapeutic goals in diabetic patients with coronary heart disease attended in primary care.
    Mostaza-Prieto JM; Martín-Jadraque L; López I; Tranche S; Lahoz C; Taboada M; Mantilla T; Soler B; Monteiro B; Sanchez-Zamorano MA
    Am Heart J; 2006 Dec; 152(6):1064-70. PubMed ID: 17161054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart rate: a cardiovascular risk factor that can no longer be ignored].
    Palatini P
    G Ital Cardiol (Rome); 2006 Feb; 7(2):119-28. PubMed ID: 16532723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug treatment of unstable angina pectoris using nitrates, beta blockers and calcium antagonists].
    Erne P
    Praxis (Bern 1994); 1995 Feb; 84(6):176-80. PubMed ID: 7871302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.